Epidemiology of Primary Headache and Its Associated Psychosocial Factors Amongst Undergraduate Medical Students: A Cross-Sectional Study From the Vidarbha Region Scientific literature GHDx Entry last modified on: Mar 22, 2024
Global Burden of Disease Study 2021 (GBD 2021) Smoking Mortality and Prevalence Forecasts 2022-2050 Estimate GHDx Entry last modified on: Jan 3, 2025
Employees of the banking sector in Guizhou Province in China: prevalence of migraine, symptoms, disability and occupational risk factors Scientific literature GHDx Entry last modified on: Mar 22, 2024
Norway Diabetes Register for Adults 2022 Norsk diabetesregister for voksne Disease registry: Nationally representative GHDx Entry last modified on: Nov 15, 2024
Philippines Expanded National Nutrition Survey 2021-2022 Survey: Household - Interview GHDx Entry last modified on: Nov 18, 2024
Mauritius Non Communicable Diseases Survey 2021 Mauritius NCD Survey 2021 Survey: Cross-sectional - Nationally representative GHDx Entry last modified on: Sep 16, 2022
Brazilian Dialysis Survey 2021 Censo Brasileiro de Diálise 2021 Scientific literature GHDx Entry last modified on: Mar 22, 2024
Brazilian Dialysis Survey 2022 Censo Brasileiro de Diálise 2022 Scientific literature GHDx Entry last modified on: Mar 22, 2024
Burkina Faso Demographic and Health Survey 2021 Enquête Démographique et de Santé du Burkina Faso (EDSBF-V) Survey: Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative GHDx Entry last modified on: Oct 11, 2024
A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021 Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021 Survey: Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Andhra Pradesh: '59% found to have Covid antibodies in sero-survey' Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint Scientific literature GHDx Entry last modified on: Sep 13, 2022
Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey Survey: Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021. Survey: Epi surveillance GHDx Entry last modified on: Jul 13, 2022
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care Scientific literature GHDx Entry last modified on: Mar 22, 2024
Primary Headaches and Physical Performance: A Professional Youth Female Soccer Team Study Scientific literature GHDx Entry last modified on: Mar 22, 2024
Serbia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Spain - Castille La Mancha Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Ukraine Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Spain Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
School-based online survey on chronic headache, migraine, and medication-overuse headache prevalence among children and adolescents in Japanese one city - Itoigawa Benizuwaigani study Scientific literature GHDx Entry last modified on: Mar 22, 2024
Finland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Belgium Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Belarus Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Portugal Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Denmark Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Spain - Basque Country Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Poland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
United Kingdom - Scotland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Spain - Andalusia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Kosovo Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Switzerland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Spain - Extremadura Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Latvia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Sweden Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Spain - Castille-Leon Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Albania Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5 Survey GHDx Entry last modified on: May 17, 2024
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study Scientific literature GHDx Entry last modified on: Mar 22, 2024
United Kingdom - England Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
France Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Croatia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA Disease registry GHDx Entry last modified on: Aug 15, 2024
Norway Diabetes Register for Adults 2021 Norsk diabetesregister for voksne Disease registry: Nationally representative GHDx Entry last modified on: Nov 15, 2024
Neuroepidemiology study of headache in the region of Jammu of north Indian population: A cross-sectional study Scientific literature GHDx Entry last modified on: Mar 22, 2024